Creative Medical Technology Holdings, Inc. (CELZ)

CELZ Statistics

Total Valuation

CELZ has a market cap or net worth of $9.09 million. The enterprise value is $2.58 million.

Market Cap	9.09M
Enterprise Value	2.58M

Important Dates

The next estimated earnings date is Friday, November 7, 2025, after market close.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	n/a

Share Statistics

CELZ has 2.58 million shares outstanding. The number of shares has increased by 35.82% in one year.

Current Share Class	2.58M
Shares Outstanding	2.58M
Shares Change (YoY)	+35.82%
Shares Change (QoQ)	+30.28%
Owned by Insiders (%)	0.49%
Owned by Institutions (%)	2.78%
Float	2.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1,518.21
Forward PS	n/a
PB Ratio	1.35
P/TBV Ratio	1.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	429.89
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 23.89, with a Debt / Equity ratio of 0.00.

Current Ratio	23.89
Quick Ratio	23.57
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -79.85% and return on invested capital (ROIC) is -51.14%.

Return on Equity (ROE)	-79.85%
Return on Assets (ROA)	-49.02%
Return on Invested Capital (ROIC)	-51.14%
Return on Capital Employed (ROCE)	-86.70%
Revenue Per Employee	$1,500
Profits Per Employee	-$1.44M
Employee Count	4
Asset Turnover	0.00
Inventory Turnover	1.09

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +12.55% in the last 52 weeks. The beta is 5.22, so CELZ's price volatility has been higher than the market average.

Beta (5Y)	5.22
52-Week Price Change	+12.55%
50-Day Moving Average	3.29
200-Day Moving Average	2.90
Relative Strength Index (RSI)	58.05
Average Volume (20 Days)	35,014

Short Selling Information

The latest short interest is 100,362, so 3.89% of the outstanding shares have been sold short.

Short Interest	100,362
Short Previous Month	117,480
Short % of Shares Out	3.89%
Short % of Float	4.60%
Short Ratio (days to cover)	2.09

Income Statement

In the last 12 months, CELZ had revenue of $6,000 and -$5.77 million in losses. Loss per share was -$3.01.

Revenue	6,000
Gross Profit	3,600
Operating Income	-5.92M
Pretax Income	-5.77M
Net Income	-5.77M
EBITDA	-5.81M
EBIT	-5.92M
Loss Per Share	-$3.01

Balance Sheet

The company has $6.54 million in cash and $14,194 in debt, giving a net cash position of $6.53 million or $2.53 per share.

Cash & Cash Equivalents	6.54M
Total Debt	14,194
Net Cash	6.53M
Net Cash Per Share	$2.53
Equity (Book Value)	6.83M
Book Value Per Share	2.65
Working Capital	6.36M

Cash Flow

Operating Cash Flow	-5.69M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	60.00%
Operating Margin	-98,656.77%
Pretax Margin	-96,093.48%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CELZ does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-35.82%
Shareholder Yield	-35.82%
Earnings Yield	-63.29%
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	507.13%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 12, 2023. It was a reverse split with a ratio of 1:10.

Last Split Date	Jun 12, 2023
Split Type	Reverse
Split Ratio	1:10

Scores

CELZ has an Altman Z-Score of -3.21 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.21
Piotroski F-Score	2